Open access
Open access
Powered by Google Translator Translator

General Interest

Trusting evidence over anecdote: Clinical decision making in the era of Covid-19

24 Jul, 2020 | 09:29h | UTC

Trusting evidence over anecdote: Clinical decision making in the era of covid-19 – The BMJ Opinion

 


What scientists are learning about how long Covid-19 immunity lasts

24 Jul, 2020 | 09:22h | UTC

What scientists are learning about how long Covid-19 immunity lasts – Vox

 


Mask mandates and other lockdown policies reduced the spread of COVID-19 in the US

24 Jul, 2020 | 09:21h | UTC

Mask mandates and other lockdown policies reduced the spread of COVID-19 in the US – World Economic Forum

 


We asked coronavirus experts when they’ll hug, pub and fly again

24 Jul, 2020 | 09:19h | UTC

We asked coronavirus experts when they’ll hug, pub and fly again – Wired

 


Swedish epidemiology boss says questioned COVID-19 strategy seems to be working

24 Jul, 2020 | 09:23h | UTC

Swedish epidemiology boss says questioned COVID-19 strategy seems to be working – Reuters

 


Why do asymptomatic COVID-19 cases even happen?

24 Jul, 2020 | 09:18h | UTC

Why do asymptomatic COVID-19 cases even happen? – National Geographic

 


Perspective: Managing uncertainty in the Covid-19 era

23 Jul, 2020 | 08:48h | UTC

Managing uncertainty in the covid-19 era – The BMJ Opinion

 


Perspective: Covid-19 vaccines with ‘minor side effects’ could still be pretty bad

23 Jul, 2020 | 08:37h | UTC

Covid-19 Vaccines With ‘Minor Side Effects’ Could Still Be Pretty Bad – Wired

 


Controversial ‘human challenge’ trials for COVID-19 vaccines gain support

23 Jul, 2020 | 08:34h | UTC

Controversial ‘human challenge’ trials for COVID-19 vaccines gain support – Science

 


Coronavirus vaccines leap through safety trials — but which will work is anybody’s guess

23 Jul, 2020 | 08:39h | UTC

Coronavirus vaccines leap through safety trials — but which will work is anybody’s guess – Nature

 


How to understand COVID-19 numbers

23 Jul, 2020 | 08:32h | UTC

How to Understand COVID-19 Numbers – ProPublica

 


Phase 2 randomized trial: immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults

21 Jul, 2020 | 09:29h | UTC

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial – The Lancet

Commentaries: China’s Ad5 vectored COVID-19 vaccine safe and induces immune response – News Medical AND CanSino COVID-19 vaccine generates immune response in 90% of patients – UPI

 

Related Commentary on Twitter

https://twitter.com/TheLancet/status/1285209554775617536

 


Editorial: encouraging results from phase 1/2 COVID-19 vaccine trials

21 Jul, 2020 | 09:35h | UTC

Encouraging results from phase 1/2 COVID-19 vaccine trials – The Lancet

Podcast: The Lancet Editor-in-Chief Richard Horton explains the current status of the Oxford and China COVID-19 vaccines

Commentaries: Promising early findings for 2 more COVID-19 vaccines – CIDRAP AND Expert reaction to two vaccine candidate studies: a phase 1/2 trial of the University of Oxford’s ChAdOx1 vaccine candidate; and a phase 2 trial of China’s Ad5-vectored COVID-19 vaccine candidate – Science Media Centre

 


Phase 1/2 randomized trial: safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2

21 Jul, 2020 | 09:33h | UTC

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial – The Lancet

Commentaries: New study reveals Oxford coronavirus vaccine produces strong immune response – University of Oxford AND Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest, but more research is needed – CNN AND Early Oxford-AstraZeneca Coronavirus Vaccine Data ‘Encouraging,’ Scientists Say – NPR

 

Related Commentary on Twitter

 


[Preprint] Covid-19: Six clusters of symptoms could be used as a clinical prediction tool

21 Jul, 2020 | 09:25h | UTC

Symptom clusters in Covid19: A potential clinical prediction tool from the COVID Symptom study app – medRxiv

Commentaries: Covid-19: Study reveals six clusters of symptoms that could be used as a clinical prediction tool – The BMJ AND Six distinct ‘types’ of COVID-19 identified – King’s College London AND Coronavirus symptoms fall into six different groupings, study finds – The Guardian

 


How (not) to write about global health

21 Jul, 2020 | 09:05h | UTC

How (not) to write about global health – The BMJ Global Health

 

Related Commentary on Twitter

 


Burnout, a silent crisis in global health

21 Jul, 2020 | 09:00h | UTC

Burnout, A Silent Crisis In Global Health – Forbes

 

Related Commentary from the Author

 


Editorial: research in the context of a pandemic

20 Jul, 2020 | 08:16h | UTC

Research in the Context of a Pandemic – New England Journal of Medicine

 

Related Commentary on Twitter

 


Study: household transmission of SARS-CoV-2 is high if the index patient is 10–19 years of age

20 Jul, 2020 | 08:14h | UTC

Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020 – CDC Emerging Infectious Diseases

Commentaries: Older Children Spread the Coronavirus Just as Much as Adults, Large Study Finds – The New York Times AND Children over age 10 spread COVID-19 as much as adults, study finds – CTV

 


Policy responses to the coronavirus pandemic

20 Jul, 2020 | 08:09h | UTC

Policy Responses to the Coronavirus Pandemic – Our World in Data

 


What counts as a Covid-19 death?

20 Jul, 2020 | 08:11h | UTC

What counts as a covid-19 death? – The BMJ

 


Is coronavirus reinfection possible?

20 Jul, 2020 | 08:01h | UTC

Is Coronavirus Reinfection Possible? – Self

 


The explosion of new coronavirus tests that could help to end the pandemic

20 Jul, 2020 | 07:57h | UTC

The explosion of new coronavirus tests that could help to end the pandemic – Nature

 


Amabié—a Japanese symbol of the COVID-19 pandemic

20 Jul, 2020 | 07:59h | UTC

The Arts & Medicine: Amabié—A Japanese Symbol of the COVID-19 Pandemic – JAMA

 

Related Commentary on Twitter

 


The Zentensivist manifesto. Defining the art of critical care

20 Jul, 2020 | 07:42h | UTC

The Zentensivist Manifesto. Defining the Art of Critical Care – ATS Scholar

Source: Grupo UTIclínica – HCFMUSP

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.